Ahmed GAD to Bevacizumab
This is a "connection" page, showing publications Ahmed GAD has written about Bevacizumab.
Connection Strength
0.051
-
Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II Trial. Oncologist. 2023 05 08; 28(5):e254-e262.
Score: 0.051
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.